A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)

Clinical trial NCT00596258 · COMPLETED

Trial details

NCT number: NCT00596258
Sponsor: Tigris Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Uterine Cervical Dysplasia

Start date: 2007-11-01
Primary completion: 2008-07-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.